KSA Retail Pharmacy Market Outlook to 2028

KSA Retail Pharmacy Market Outlook to 2028

KSA Retail Pharmacy

Market Overview

The KSA retail pharmacy market was valued at 7.19 billion USD in 2023, driven by growing population expanding the customer base, rising chronic diseases leading to increased demand for health & wellness products, introduction of e-prescription platforms resulting in higher volume of prescriptions per pharmacy, and increasing consumer expenditure on healthcare.

The retail pharmacy market in KSA is dominated by key players such as Nahdi Medical Company, Al-Dawaa Medical Services Co., United Pharmacies, Planet Pharmacy (Acquired by Gulf Pharmaceuticals Industries (Julphar)), and GHC Group (Kunooz Pharmacy and Whites). These players have established a strong presence through extensive networks, customer loyalty programs, and a diverse product range that includes both over-the-counter and prescription medicines.

In 2022, Nahdi Medical Company launched IMDAD, a state-of-the-art Smart Logistics & Distribution Center, strategically located to serve the entire Kingdom of Saudi Arabia. Spanning an impressive 250,000 square meters, IMDAD is designed to enhance Nahdi's supply chain efficiency and capabilities significantly.

Riyadh, Jeddah, and Dammam are the dominant cities in the KSA retail pharmacy market, accounting for a significant portion of the market share. Riyadh, the capital city, leads due to its large population and the presence of numerous healthcare facilities, which drive demand for pharmaceutical products.

KSA Retail Pharmacy

Market Segmentation

The KSA Retail Pharmacy market is segmented by various factors like product, application, and region.

By Product Category: The KSA retail pharmacy market is segmented by product category into prescribed drugs, OTC (Over-the-Counter) drugs, beauty care, cosmetics, baby products, wellness products, and medical equipment & materials. In 2023, the wellness products segment dominated the market due to a growing consumer focus on health and preventive care. The increasing awareness of fitness and well-being, coupled with the rising demand for supplements, vitamins, and health-related products, has driven the expansion of this segment.

By Type of Pharmacy: The KSA retail pharmacy market is segmented by the type of pharmacy into pharmacy chains, standalone pharmacies, and hospital-attached pharmacies. In 2023, pharmacy chains held the largest market share, driven by their extensive networks and standardized service offerings across multiple locations. Pharmacy chains like Nahdi and Al-Dawaa have established a strong market presence by providing a consistent customer experience, and offering a wide range of products.

By Region: The KSA retail pharmacy market is segmented by region into Riyadh, Jeddah, Eastern Region (including Dammam, Al-Ahsa, Hafr-Al Baten, etc.), Makkah, Aseer, Madinah, Jazan, Qaseem, and the rest of KSA (including Taif, Tabouk, Ha`il, Najran, Al-Jouf, Al-Baha, Bishah, Qunfudah, Qurayyat, etc.). Riyadh dominated the market in 2023 due to its status as the capital and largest city in the Kingdom, with a dense population and a high concentration of healthcare facilities.

KSA Retail Pharmacy Market

Competitive Landscape

Company Name
Year of Establishment
Geographical Spread (2023)
Number of Pharmacy (2023)
Nahdi Medical Company
1986
140+ cities
1,120
Al-Dawaa Medical Services Co.
1991
131 Cities
890
United Pharmaceuticals Company
1990
44 Cities
325
Planet Pharmacy (Acquired by Gulf Pharmaceuticals Industries (Julphar))
2007
15+ Cities
~170
GHC Group (Kunooz Pharmacy and Whites)
2007
22+ Cities
220+
Innova Pharmacies
1994
15 Cities
~178
Al Mujtama
2001
9 Cities
125
Al-Dawaa Medical Services Co.: In 2021, Al-Dawaa Medical Services Co. significantly expanded its retail footprint by opening 50 new pharmacies across various regions of Saudi Arabia. This strategic move was part of Nahdi’s broader growth plan to increase its accessibility and service coverage, particularly in underserved areas where the need for quality healthcare services is rapidly growing.
Planet Pharmacy: In 2021, Gulf Pharmaceuticals Industries, commonly known as Julphar, made a strategic move to strengthen its footprint in the retail pharmacy sector by acquiring a significant stake in Planet Pharmacies. This acquisition was a key component of Julphar's broader strategy to deepen its presence and expand its operations across the Kingdom of Saudi Arabia.

KSA Retail Pharmacy

Market Analysis

Growth Drivers

Expanding Population Enhancing Customer Base: The population of Saudi Arabia is projected to grow from 36 million in 2023 to 40 million by 2030, leading to a broader customer base for pharmacies, encompassing both Saudi nationals and expatriates. Additionally, the increasing participation of women in the workforce is driving up sales of non-pharmaceutical products, such as beauty and mom & baby items, predominantly sold through retail pharmacies. Major pharmacy chains like Nahdi and Al Dawaa are responding to this expanding customer base and changing demands by diversifying their product ranges.

Rising Chronic Diseases Boosting Demand for Health & Wellness Products: The prevalence of diabetes in Saudi Arabia has increased from 15.8% in 2018 to 20.2% in 2023 and is expected to climb to 26.3% by 2028. Similarly, obesity rates have grown from 37.7% in 2018 to 40.6% in 2023, with projections suggesting a rise to 43.5%. This growing burden of chronic diseases, including diabetes, obesity, and heart disease, is driving consumers to prioritize health and wellness, leading to increased purchases of products like vitamins, protein supplements, and Omega-3 or fish oil tablets from pharmacies.

Increasing Consumer Spending on Healthcare: Consumer spending on healthcare in Saudi Arabia has risen from SAR 18 billion in 2018 to SAR 21 billion in 2023, marking an approximate 17% increase during this period. This heightened expenditure is boosting the demand for both pharmaceutical and non-pharmaceutical products, as consumers are increasingly willing to invest in healthcare, including wellness products and home-based medical devices like blood sugar monitors and blood pressure equipment.

Challenges

Regulatory Compliance Pressuring Pharmacy Profit Margins: The Saudi government’s regulation of pharmaceutical product prices limits the profit margins for pharmacies, making it challenging for them to compete based on price alone. Additionally, the government's emphasis on promoting generic drugs further compresses profitability, particularly for smaller independent pharmacies, as these products come with significantly lower prices and margins.

Intense Competition Leading to Market Saturation: With over 10,000 pharmacies operating across Saudi Arabia, the market is highly competitive, making it difficult for new or smaller players to gain market share. Established pharmacy chains like Al Nahdi and Al Dawaa have created significant entry barriers by leveraging their extensive networks and size to secure lower prices from suppliers, enabling them to offer more competitive pricing to customers. Al Nahdi, with more than 1,200 outlets, also invests heavily in marketing and loyalty programs to attract and retain customers.

Government Initiatives

Healthcare Transformation Plan: Saudi Arabia has launched an ambitious healthcare transformation plan under Vision 2030, aimed at privatizing 295 hospitals by 2030 to improve quality and efficiency. Key initiatives include establishing health clusters, creating the National Centre for Privatization & PPP, and enacting the Private Sector Participation (PSP) Law to facilitate the privatization process and attract private investment in the healthcare sector.

Regulation of Pharmaceutical Prices and Promotion of Generic Drugs:The Saudi Food and Drug Authority (SFDA) has implemented stringent regulations on pharmaceutical pricing to ensure affordability and accessibility of medications for the population. Alongside this, the government has been actively promoting the use of generic drugs as a cost-effective alternative to branded medications.

KSA Retail Pharmacy Future Market Outlook

The KSA retail pharmacy market is poised for remarkable growth reaching a market size of 9.06 billion USD driven by transition to integrated stores from smaller stores, emphasis on generic drugs, and growing sales from ecommerce.

Future Market Trends

Transition to Integrated Stores from Smaller Stores: The retail pharmacy market in Saudi Arabia is expected to witness a shift from smaller, standalone stores to larger, integrated pharmacy outlets. These integrated stores will combine a wide range of services and products under one roof, offering not only pharmaceuticals but also health and wellness products, beauty care, and even on-site medical consultations.

Emphasis on Generic Drugs: The Saudi government and healthcare providers will increasingly promote the use of generic drugs as a cost-effective alternative to branded medications. This trend will be driven by the need to reduce healthcare costs while maintaining access to essential medicines for the population. As a result, pharmacies are expected to place greater emphasis on stocking and selling generic drugs, which are chemically equivalent to their branded counterparts but will be offered at significantly lower prices.

Please Note: It will take 5-7 business days to complete the report upon order confirmation.